Damon Runyon Innovative Ventures in Early-Stage Technologies (InVEST) Program
The Damon Runyon Cancer Research Foundation announces a new initiative, the Innovative Ventures in Early-Stage Technologies (InVEST) Program. The program establishes a manner through which Damon Runyon will invest in healthcare- or research-related companies founded by Damon Runyon alumni or current Damon Runyon-Rachleff Innovators or Damon Runyon Clinical Investigators. 

The program will provide a $50,000 investment to support any new company started by Damon Runyon scientists who activated their Damon Runyon awards on or after January 1, 2000. Currently funded Damon Runyon scientists who are in mentored positions are not eligible to request support. Investments will be limited to companies that are raising seed or Series A rounds and are less than three years old. 

Requests will be accepted on a rolling basis each fiscal year (July 1-June 30). To ensure consideration within the current fiscal year, applications must be submitted no later than June 1. Applications received after this date will be reviewed in the following fiscal year.

If you have any questions, please email InVEST@damonrunyon.org
Sign in to Google to save your progress. Learn more
Email *
APPLICANT INFORMATION
Name *
First and last name
Email *
Phone number *
Degree(s)  *
Damon Runyon Award(s) received *
Required
Approximate dates of funding *
Provide a link to your LinkedIn profile *
COMPANY INFORMATION
Company name *
Mission and/or therapeutic goal of the company *
Year founded *
List the names of other scientific co-founders
 *
Applicant's current role at company (founder, SAB, CSO, etc.)
 *
Percentage of the company’s equity currently held as a co-founder   *
Current funding round *
Expected amount to be raised in this current round *
Total amount raised to date *
List other funders (angel/friends and family, VCs) *
An approximate current valuation of the company *
Eligibility for funding requires the scientific founder to uphold the highest standards of scientific integrity. Damon Runyon will not release funds to a company if its founder has a history of ethical violations, is currently under investigation for scientific misconduct, or has been involved in criminal activity. Please confirm that you have never been under investigation, nor have you been found guilty of scientific or ethical misconduct, or criminal behavior. *
Required
Certain areas of biomedical research are considered unethical or are ineligible for funding due to the danger it may pose to human health. Please confirm that your company does not work on the following: germline gene editing, agricultural gene editing to create sterile seeds or gene drives, and/or gene editing related to tobacco use. *
Required
A copy of your responses will be emailed to the address you provided.
Submit
Clear form
Never submit passwords through Google Forms.
reCAPTCHA
PrivacyTerms
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Google Forms